Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Geron
Biotech
Cabaletta corrals cell therapy Legend—Chutes & Ladders
Cabaletta corrals cell therapy Legend. Ashvattha eyes growth with ophthalmology vet as interim CEO. Alentis adopts seasoned CEO as leader.
Darren Incorvaia
,
Zoey Becker
Oct 17, 2025 8:30am
Altos ascends with new clinical leader—Chutes & Ladders
Aug 8, 2025 8:30am
Gilead's accounting chief hits the exit—Chutes & Ladders
Mar 14, 2025 8:30am
Pfizer replaces retiring CSO with cancer chief—Chutes & Ladders
Nov 22, 2024 8:30am
Moderna, Terremoto, MEI Pharma and more—Chutes & Ladders
Jul 26, 2024 8:30am
Geron secures 12-2 AdComm vote in favor of blood cancer drug
Mar 15, 2024 5:00am